Rationale and design of a randomized, controlled, superiority trial on areca nut/betel quid cessation: The Betel Nut Intervention Trial (BENIT)

Background: Areca nut (AN) is the seed endosperm of the Areca catechu L. palm and a Group 1 carcinogen chewed by 10–20% of the world population. AN is often chewed with Piper betle L. leaf, slaked lime, and tobacco to form a betel quid (BQ). The negative health effects associated with AN/BQ consumpt...

Full description

Bibliographic Details
Main Authors: Yvette C. Paulino, Lynne R. Wilkens, Patrick P. Sotto, Adrian A. Franke, Crissy T. Kawamoto, Jade S.N. Chennaux, Ana Joy Mendez, Lynnette F. Tenorio, Grazyna Badowski, Pallav Pokhrel, Thaddeus A. Herzog
Format: Article
Language:English
Published: Elsevier 2020-03-01
Series:Contemporary Clinical Trials Communications
Online Access:http://www.sciencedirect.com/science/article/pii/S2451865420300284
id doaj-6011c00cc37a48f2bb177fb9890e78bf
record_format Article
spelling doaj-6011c00cc37a48f2bb177fb9890e78bf2020-11-25T02:24:31ZengElsevierContemporary Clinical Trials Communications2451-86542020-03-0117Rationale and design of a randomized, controlled, superiority trial on areca nut/betel quid cessation: The Betel Nut Intervention Trial (BENIT)Yvette C. Paulino0Lynne R. Wilkens1Patrick P. Sotto2Adrian A. Franke3Crissy T. Kawamoto4Jade S.N. Chennaux5Ana Joy Mendez6Lynnette F. Tenorio7Grazyna Badowski8Pallav Pokhrel9Thaddeus A. Herzog10University of Guam Cancer Research Center, University Dr, House 7, Dean's Circle UOG Station, Mangilao, GU, 96923, USA; Corresponding author. University of Guam Cancer Research Center, House 7, Dean's Circle, UOG station, Mangilao, GU, 96923, USA.University of Hawaii Cancer Center, 701 Ilalo St, Honolulu, HI, 96813, USAUniversity of Guam Cancer Research Center, University Dr, House 7, Dean's Circle UOG Station, Mangilao, GU, 96923, USAUniversity of Hawaii Cancer Center, 701 Ilalo St, Honolulu, HI, 96813, USAUniversity of Hawaii Cancer Center, 701 Ilalo St, Honolulu, HI, 96813, USAUniversity of Guam Cancer Research Center, University Dr, House 7, Dean's Circle UOG Station, Mangilao, GU, 96923, USAUniversity of Guam Cancer Research Center, University Dr, House 7, Dean's Circle UOG Station, Mangilao, GU, 96923, USAUniversity of Guam Cancer Research Center, University Dr, House 7, Dean's Circle UOG Station, Mangilao, GU, 96923, USAUniversity of Guam Cancer Research Center, University Dr, House 7, Dean's Circle UOG Station, Mangilao, GU, 96923, USAUniversity of Hawaii Cancer Center, 701 Ilalo St, Honolulu, HI, 96813, USAUniversity of Hawaii Cancer Center, 701 Ilalo St, Honolulu, HI, 96813, USABackground: Areca nut (AN) is the seed endosperm of the Areca catechu L. palm and a Group 1 carcinogen chewed by 10–20% of the world population. AN is often chewed with Piper betle L. leaf, slaked lime, and tobacco to form a betel quid (BQ). The negative health effects associated with AN/BQ consumption warrant the need for an evidence-based cessation program. However, systematic research on AN/BQ cessation is rare. Methods/design: The Betel Nut Intervention Trial (BENIT; trial #NCT02942745) is a randomized controlled trial designed to test the efficacy of an intensive AN/BQ cessation program. The trial is ongoing in Guam and Saipan with adult chewers who include tobacco in their BQ. Enrolled participants are assessed for their primary (chewing status) and secondary (saliva bio-verification) outcome at baseline, 22 days, and 6 months. Participants randomized into the control arm receive an educational booklet while those randomized into the intervention arm receive the educational booklet and a 22-day cessation program modeled after a smoking cessation program and led by trained facilitators. Information on chewing behavior (history, reasons for chewing, and AN/BQ composition and dependency) are collected. The intervention effectiveness is assessed using the logistic mixed model to compare cessation status between randomization groups. Discussion: AN/BQ chewing affects a large population of people, many of whom live in low and moderate income countries in the Asia-Pacific region. Although the BENIT focuses on chewers in Guam and Saipan, it has the potential for greater regional and global importance. Keywords: Areca nut, Betel quid, BENIT, Cessation, Guam, Saipanhttp://www.sciencedirect.com/science/article/pii/S2451865420300284
collection DOAJ
language English
format Article
sources DOAJ
author Yvette C. Paulino
Lynne R. Wilkens
Patrick P. Sotto
Adrian A. Franke
Crissy T. Kawamoto
Jade S.N. Chennaux
Ana Joy Mendez
Lynnette F. Tenorio
Grazyna Badowski
Pallav Pokhrel
Thaddeus A. Herzog
spellingShingle Yvette C. Paulino
Lynne R. Wilkens
Patrick P. Sotto
Adrian A. Franke
Crissy T. Kawamoto
Jade S.N. Chennaux
Ana Joy Mendez
Lynnette F. Tenorio
Grazyna Badowski
Pallav Pokhrel
Thaddeus A. Herzog
Rationale and design of a randomized, controlled, superiority trial on areca nut/betel quid cessation: The Betel Nut Intervention Trial (BENIT)
Contemporary Clinical Trials Communications
author_facet Yvette C. Paulino
Lynne R. Wilkens
Patrick P. Sotto
Adrian A. Franke
Crissy T. Kawamoto
Jade S.N. Chennaux
Ana Joy Mendez
Lynnette F. Tenorio
Grazyna Badowski
Pallav Pokhrel
Thaddeus A. Herzog
author_sort Yvette C. Paulino
title Rationale and design of a randomized, controlled, superiority trial on areca nut/betel quid cessation: The Betel Nut Intervention Trial (BENIT)
title_short Rationale and design of a randomized, controlled, superiority trial on areca nut/betel quid cessation: The Betel Nut Intervention Trial (BENIT)
title_full Rationale and design of a randomized, controlled, superiority trial on areca nut/betel quid cessation: The Betel Nut Intervention Trial (BENIT)
title_fullStr Rationale and design of a randomized, controlled, superiority trial on areca nut/betel quid cessation: The Betel Nut Intervention Trial (BENIT)
title_full_unstemmed Rationale and design of a randomized, controlled, superiority trial on areca nut/betel quid cessation: The Betel Nut Intervention Trial (BENIT)
title_sort rationale and design of a randomized, controlled, superiority trial on areca nut/betel quid cessation: the betel nut intervention trial (benit)
publisher Elsevier
series Contemporary Clinical Trials Communications
issn 2451-8654
publishDate 2020-03-01
description Background: Areca nut (AN) is the seed endosperm of the Areca catechu L. palm and a Group 1 carcinogen chewed by 10–20% of the world population. AN is often chewed with Piper betle L. leaf, slaked lime, and tobacco to form a betel quid (BQ). The negative health effects associated with AN/BQ consumption warrant the need for an evidence-based cessation program. However, systematic research on AN/BQ cessation is rare. Methods/design: The Betel Nut Intervention Trial (BENIT; trial #NCT02942745) is a randomized controlled trial designed to test the efficacy of an intensive AN/BQ cessation program. The trial is ongoing in Guam and Saipan with adult chewers who include tobacco in their BQ. Enrolled participants are assessed for their primary (chewing status) and secondary (saliva bio-verification) outcome at baseline, 22 days, and 6 months. Participants randomized into the control arm receive an educational booklet while those randomized into the intervention arm receive the educational booklet and a 22-day cessation program modeled after a smoking cessation program and led by trained facilitators. Information on chewing behavior (history, reasons for chewing, and AN/BQ composition and dependency) are collected. The intervention effectiveness is assessed using the logistic mixed model to compare cessation status between randomization groups. Discussion: AN/BQ chewing affects a large population of people, many of whom live in low and moderate income countries in the Asia-Pacific region. Although the BENIT focuses on chewers in Guam and Saipan, it has the potential for greater regional and global importance. Keywords: Areca nut, Betel quid, BENIT, Cessation, Guam, Saipan
url http://www.sciencedirect.com/science/article/pii/S2451865420300284
work_keys_str_mv AT yvettecpaulino rationaleanddesignofarandomizedcontrolledsuperioritytrialonarecanutbetelquidcessationthebetelnutinterventiontrialbenit
AT lynnerwilkens rationaleanddesignofarandomizedcontrolledsuperioritytrialonarecanutbetelquidcessationthebetelnutinterventiontrialbenit
AT patrickpsotto rationaleanddesignofarandomizedcontrolledsuperioritytrialonarecanutbetelquidcessationthebetelnutinterventiontrialbenit
AT adrianafranke rationaleanddesignofarandomizedcontrolledsuperioritytrialonarecanutbetelquidcessationthebetelnutinterventiontrialbenit
AT crissytkawamoto rationaleanddesignofarandomizedcontrolledsuperioritytrialonarecanutbetelquidcessationthebetelnutinterventiontrialbenit
AT jadesnchennaux rationaleanddesignofarandomizedcontrolledsuperioritytrialonarecanutbetelquidcessationthebetelnutinterventiontrialbenit
AT anajoymendez rationaleanddesignofarandomizedcontrolledsuperioritytrialonarecanutbetelquidcessationthebetelnutinterventiontrialbenit
AT lynnetteftenorio rationaleanddesignofarandomizedcontrolledsuperioritytrialonarecanutbetelquidcessationthebetelnutinterventiontrialbenit
AT grazynabadowski rationaleanddesignofarandomizedcontrolledsuperioritytrialonarecanutbetelquidcessationthebetelnutinterventiontrialbenit
AT pallavpokhrel rationaleanddesignofarandomizedcontrolledsuperioritytrialonarecanutbetelquidcessationthebetelnutinterventiontrialbenit
AT thaddeusaherzog rationaleanddesignofarandomizedcontrolledsuperioritytrialonarecanutbetelquidcessationthebetelnutinterventiontrialbenit
_version_ 1724855221726740480